Medications for Polycythemia Vera
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Polycythemia Vera.
Found 2 Approved Drugs for Polycythemia Vera
Ruxolitinib
Brand Names
Opzelura, Jakafi
Ruxolitinib
Brand Names
Opzelura, Jakafi
Form: Cream, Tablet
Method of administration: Oral, Topical
FDA approval date: November 16, 2011
Classification: Janus Kinase Inhibitor
OPZELURA is a Janus kinase (JAK) inhibitor indicated for: the topical short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised adult and pediatric patients 2 years of age and older whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.
BESREMi
Generic Name
Ropeginterferon alfa-2B
BESREMi
Generic Name
Ropeginterferon alfa-2B
Form: Injection
Method of administration: Subcutaneous
FDA approval date: November 12, 2021
Classification: Interferon alfa-2b
BESREMi is indicated for the treatment of adults with polycythemia vera. BESREMi is an interferon alfa-2b indicated for the treatment of adults with polycythemia vera ( 1 )
Showing 1-2 of 2
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances